Ali Behbahani Insider Trading $GNCA GENOCEA BIOSCIENCES, INC.
Get free email notifications about insider trading for Ali Behbahani.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ali Behbahani. Ali Behbahani is 10% Owner in Marker Therapeutics, Inc. ($MRKR) and Director in NEVRO CORP ($NVRO) and Director in GENOCEA BIOSCIENCES, INC. ($GNCA) and 10% Owner in Regulus Therapeutics Inc. ($RGLS) and 10% Owner in Trevi Therapeutics, Inc. ($TRVI) and Director in Adaptimmune Therapeutics PLC ($ADAP) and 10% Owner in Metacrine, Inc. ($MTCR) and Director in CRISPR Therapeutics AG ($CRSP) and Director in Black Diamond Therapeutics, Inc. ($BDTX) and Director in Oyster Point Pharma, Inc. ($OYST) and 10% Owner in Akouos, Inc. ($AKUS) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and Director in Nkarta, Inc. ($NKTX).
Ali Behbahani in GENOCEA BIOSCIENCES, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Ali Behbahani: Director
Holdings: 10,376,936 shares
Current Value: $46,799,981
Latest Transaction: Jul 28 2020
$GNCA Market Capitalization: $129.13M
$GNCA Previous Close: $4.51
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Ali Behbahani in GENOCEA BIOSCIENCES, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADAP, AKUS, BDTX, CRSP, GNCA, MRKR, MTCR, MIRM, NVRO, NKTX, OYST, RGLS, TRVI
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 28 2020 | GNCA | GENOCEA BIOSCIENCE ... | Behbahani Ali | Director | Option Exercise | P | 2.25 | 3,151,260 | 7,090,335 | 3,151,260 | |
| Jul 28 2020 | GNCA | GENOCEA BIOSCIENCE ... | Behbahani Ali | Director | Buy | P | 2.25 | 3,151,260 | 7,090,335 | 10,376,936 | 7.2 M to 10.4 M (+43.61 %) |
| Jun 19 2020 | GNCA | GENOCEA BIOSCIENCE ... | Behbahani Ali | Director | Option Exercise | A | 2.22 | 15,000 | 33,300 | 15,000 | |
| Jul 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | Behbahani Ali | Director | Option Exercise | A | 3.66 | 5,625 | 20,588 | 5,625 | |
| Jun 25 2019 | GNCA | GENOCEA BIOSCIENCE ... | Behbahani Ali | Director | Buy | P | 3.50 | 2,857,142 | 9,999,997 | 7,225,676 | 4.4 M to 7.2 M (+65.40 %) |
| Jun 25 2019 | GNCA | GENOCEA BIOSCIENCE ... | Behbahani Ali | Director | Buy | P | 3.50 | 2,857,142 | 9,999,997 | 7,225,676 | 4.4 M to 7.2 M (+65.40 %) |
| Feb 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | Behbahani Ali | Director | Option Exercise | P | 0.57 | 2,487,067 | 1,406,685 | 2,487,067 | |
| Feb 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | Behbahani Ali | Director | Buy | P | 0.47 | 9,948,269 | 4,688,619 | 34,948,269 | 25 M to 34.9 M (+39.79 %) |
| Jun 25 2018 | GNCA | GENOCEA BIOSCIENCE ... | Behbahani Ali | Director | Option Exercise | A | 0.99 | 50,000 | 49,500 | 50,000 | |
| Feb 12 2018 | GNCA | GENOCEA BIOSCIENCE ... | Behbahani Ali | Director | Option Exercise | A | 0.98 | 25,000 | 24,500 | 25,000 |
Page: 1